查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲目标定序市场：按应用、按产品类型、按靶向序列捕获方法、按目标捕获类型、按最终用户、按国家/地区 - 分析和预测 (2024-2033)
市场调查报告书
商品编码
1614810

欧洲目标定序市场：按应用、按产品类型、按靶向序列捕获方法、按目标捕获类型、按最终用户、按国家/地区 - 分析和预测 (2024-2033)

Europe Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 61 Pages | 商品交期: 1-5个工作天内

价格

2023年欧洲标靶定序市场规模达8.038亿美元。

预计2024年至2033年该市场将以11.53%的复合年增长率成长，2033年达到23.733亿美元。欧洲靶向定序市场竞争激烈，现有企业和新参与企业都在争夺市场占有率。市场的预期成长和演变带来了挑战和机会，未来几年作为一个充满活力和快速变化的市场需要密切关注。

主要市场统计数据
预测期 2024-2033
2024年评估 8.888 亿美元
2033 年预测 23.733 亿美元
复合年增长率 11.53%

由于个人化治疗、基因组研究以及癌症和遗传疾病发病率上升等发展，欧洲靶向定序市场预计将显着增长。临床诊断、药物开发和研究应用越来越多地使用标靶定序，这是一种用于询问特定基因组区域的准确且廉价的技术。它比传统定序技术更受青睐，因为它可以在更短的时间内以更低的成本提供高解析度资料。

由于该地区在基因组分析和生物技术开发投资的推动下对医疗保健创新的关注，该市场正在不断增长。强大的医疗保健系统和政府对基因组研究的津贴正在加速德国、英国和法国等国家的靶向定序技术的使用。此外，该市场还受益于对严重依赖准确基因分析的个人化医疗和伴同性诊断不断增长的需求。

然而，挑战仍然存在，包括高昂的前期成本、复杂的资料解释和监管障碍。然而，持续的创新，例如生物资讯学和人工智慧的融合，有望解决这些问题并创造新的前景。由于临床和研究领域的接受度不断提高，欧洲标靶定序市场预计将成为基因组学和精准医疗进步不可或缺的一部分。

该报告调查了欧洲目标定序市场，并按应用、产品类型、靶向序列捕获、目标捕获类型、最终用户、国家和市场参与者提供了市场概述。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
  • 标靶定序工作流程
  • 研究发展回顾
  • 监管状况
  • 市场动态：概述
    • 市场驱动因素
    • 市场限制因素
    • 市场机会

第二章 区域

  • 区域概况
  • 促进因素和抑制因素
  • 欧洲
    • 区域概况
    • 法国
    • 德国
    • 英国
    • 西班牙
    • 义大利
    • 其他的

第三章市场－竞争基准化分析和

  • 公司简介
  • 未来展望
  • 竞争格局
    • F. Hoffmann-La Roche Ltd
    • LGC Limited
    • QIAGEN NV

第四章调查方法

Product Code: BHP2404SS

Introduction to Europe Targeted Sequencing Market

The Europe targeted sequencing market was valued at $803.8 million in 2023 and is expected to reach $2,373.3 million by 2033, growing at a CAGR of 11.53% between 2024 and 2033. The Europe targeted sequencing market is highly competitive, with established companies and new entrants vying for market share. The market's anticipated growth and evolution present a mix of challenges and opportunities, positioning it as a dynamic and rapidly changing landscape to monitor in the coming years.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$888.8 Million
2033 Forecast$2,373.3 Million
CAGR11.53%

The market for targeted sequencing in Europe is expected to increase significantly due to developments in customized treatment, genomic research, and the rising incidence of cancer and genetic disorders. Clinical diagnostics, medication development, and research applications are increasingly using targeted sequencing, a precise and affordable technique for examining particular genome regions. It is favored over conventional sequencing techniques because it may produce high-resolution data in less time and at a lower cost.

The market is growing as a result of the region's strong emphasis on healthcare innovation, which is bolstered by investments in genomics and biotechnological developments. Targeted sequencing technology use is accelerating in nations like Germany, the UK, and France thanks to strong healthcare systems and government funding for genomic research. Additionally, the market gains from the growing demand for personalized medicine and companion diagnostics, which rely heavily on precise genetic analysis.

Nevertheless, issues including exorbitant upfront expenses, intricate data interpretation, and regulatory barriers continue to exist. Nevertheless, it is anticipated that ongoing innovation, such as the fusion of bioinformatics and artificial intelligence, will resolve these issues and create new prospects. The targeted sequencing market in Europe is expected to be crucial to the advancement of genomics and precision healthcare due to its growing acceptance in the clinical and research sectors.

Market Segmentation

Segmentation 1: by Application

  • Cancer
  • Reproductive Health
  • Hereditary Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Other Applications

Segmentation 2: by End User

  • Diagnostic and Clinical Laboratories
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other End Users

Segmentation 3: by Product Type

  • Instruments
  • Services
  • Kits/Panels and Assays
  • Others

Segmentation 4: by Target Enrichment Method

  • Hybridization Capture
  • Amplicon Sequencing
  • Other Target Enrichment Methods

Segmentation 5: by Target Capture

  • Targeted DNA Sequencing
  • Targeted RNA Sequencing
  • Other Types of Target Capture

Segmentation 6: by Country

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Europe targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some of the prominent companies in this market are:

  • F. Hoffmann-La Roche Ltd
  • LGC Limited
  • QIAGEN N.V.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Number of Targeted Sequencing Products and Services in the Market
    • 1.1.2 Increasing Synergistic Partnerships between Market Players
  • 1.2 Targeted Sequencing Workflow
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Increasing Demand for High Depth of Coverage in Sequencing
      • 1.5.1.2 Cost and Data Management Benefits of Targeted Sequencing as Compared to WGS
    • 1.5.2 Market Restraints
      • 1.5.2.1 Lack of Advanced Genomic Testing Centers
      • 1.5.2.2 Lack of Knowledge about New Genes
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Increasing Use in Clinical Research and Trials for Better Disease Pathogenesis and/or Clinical Relevance
      • 1.5.3.2 Increasing Adoption in Targeted Therapeutics in Oncology

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
      • 2.3.1.1 Driving Factors for Market Growth
      • 2.3.1.2 Factors Challenging the Market
    • 2.3.2 Application
    • 2.3.3 Product
    • 2.3.4 France
    • 2.3.5 Application
    • 2.3.6 Product
    • 2.3.7 Germany
    • 2.3.8 Application
    • 2.3.9 Product
    • 2.3.10 U.K.
    • 2.3.11 Application
    • 2.3.12 Product
    • 2.3.13 Spain
    • 2.3.14 Application
    • 2.3.15 Product
    • 2.3.16 Italy
    • 2.3.17 Application
    • 2.3.18 Product
    • 2.3.19 Rest-of-Europe
    • 2.3.20 Application
    • 2.3.21 Product

3 Markets - Competitive Benchmarking &

Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Landscape
    • 3.2.1 F. Hoffmann-La Roche Ltd
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View
    • 3.2.2 LGC Limited
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Target Customers
      • 3.2.2.5 Key Personnel
      • 3.2.2.6 Analyst View
    • 3.2.3 QIAGEN N.V.
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products
      • 3.2.3.3 Top Competitors
      • 3.2.3.4 Target Customers
      • 3.2.3.5 Key Personnel
      • 3.2.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Targeted Sequencing Market, $Million, 2024, 2027, and 2033
  • Figure 2: Targeted Sequencing Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Europe Targeted Sequencing Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Europe Targeted Sequencing Market (by Target Enrichment Method), $Million, 2023, 2027, and 2033
  • Figure 5: Europe Targeted Sequencing Market (by Target Capture), $Million, 2023, 2027, and 2033
  • Figure 6: Europe Targeted Sequencing Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 7: Europe Targeted Sequencing Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 8: Key Industrial Developments in Europe Targeted Sequencing Market, 2023
  • Figure 9: Workflow of Targeted Sequencing
  • Figure 10: Targeted Sequencing Market, Number of Patents (by Country), January 2019-February 2024
  • Figure 11: Targeted Sequencing Market (by Year), January 2019-February 2024
  • Figure 12: France Targeted Sequencing Market, $Million, 2023-2033
  • Figure 13: Germany Targeted Sequencing Market, $Million, 2023-2033
  • Figure 14: U.K. Targeted Sequencing Market, $Million, 2023-2033
  • Figure 15: Spain Targeted Sequencing Market, $Million, 2023-2033
  • Figure 16: Italy Targeted Sequencing Market, $Million, 2023-2033
  • Figure 17: Rest-of-Europe Targeted Sequencing Market, $Million, 2023-2033
  • Figure 18: Share of Strategic Initiatives
  • Figure 19: Data Triangulation
  • Figure 20: Top-Down and Bottom-Up Approach
  • Figure 21: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Europe Targeted Sequencing Market, Opportunities
  • Table 3: Europe Targeted Sequencing Market, Trend Analysis
  • Table 4: Some Product Launches in the Targeted Sequencing Market
  • Table 5: Targeted Sequencing Market, Key Partnerships and Collaborations
  • Table 6: Targeted Sequencing Market, Regulatory Landscape
  • Table 7: Impact Analysis of Market Navigating Factors, 2023-2033
  • Table 8: Comparison Between Types of Next-Generation Sequencing Techniques
  • Table 9: Targeted Sequencing Market (by Region), $Million, 2023-2033
  • Table 10: Europe Targeted Sequencing Market (by Application), $Million, 2023-2033
  • Table 11: Europe Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 12: Europe Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 13: Europe Targeted Sequencing Market (by Target Enrichment Methods), $Million, 2023-2033
  • Table 14: Europe Targeted Sequencing Market (by Type of Target Capture), $Million, 2023-2033
  • Table 15: France Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 16: France Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 17: Germany Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 18: Germany Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 19: U.K. Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 20: U.K. Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 21: Spain Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 22: Spain Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 23: Italy Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 24: Italy Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 25: Rest-of-Europe Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 26: Rest-of-Europe Targeted Sequencing Market (by Product Type), $Million, 2023-2033